Written and maintained by CASRAI Editorial Board
Last updated
DKFZ stands for the Deutsches Krebsforschungszentrum (German Cancer Research Center), Germany’s largest biomedical research institute and a member of the Helmholtz Association of German Research Centres. Headquartered in Heidelberg, Germany, DKFZ operates over 100 research divisions and 21 scientific core facilities, employing more than 3,600 staff dedicated to investigating cancer mechanisms, identifying risk factors, and translating biological discoveries into clinical cancer therapies.
What Is DKFZ and Who Runs It?
The Deutsches Krebsforschungszentrum (DKFZ), also widely known as the German Cancer Research Center or DKFZ Heidelberg, operates as a public research foundation under the laws of the State of Baden-Württemberg. DKFZ is a core member of the Helmholtz Association of German Research Centres, Germany’s largest scientific organisation. Scientific and strategic direction is led by Scientific Director and Management Board Chairman Prof. Dr. med. Dr. h. c. Michael Baumann, working alongside interim Administrative Director Shalini Saxena.
Institutional funding reflects a dual public financing model: basic institutional funding is provided jointly by the German Federal Ministry of Education and Research (BMBF, contributing 90%) and the State of Baden-Württemberg’s Ministry of Science, Research and Arts (MWK, contributing 10%). Across basic funding, competitive research awards, industry collaborations, and philanthropy, DKFZ operates with an annual budget of approximately EUR 515 million.
The Five DKFZ Research Focus Areas
DKFZ structures its basic, epidemiological, and pre-clinical investigations across five core Research Programs, which undergo periodic international peer reviews to ensure scientific excellence:
- Cell and Tumor Biology: Investigating the fundamental cell biology of malignancy, including cell cycle dysregulation, oncogenic signaling cascades, tumour microenvironment dynamics, and mechanisms of therapy resistance.
- Functional and Structural Genomics: Mapping cancer genome alterations, epigenetic reprogramming, and macromolecular structures, generating translational genomic targets comparable to international reference cohorts like The Cancer Genome Atlas (TCGA).
- Epidemiology, Public Health, Prevention and Survivorship: Quantifying cancer risk factors, evaluating lifestyle and environmental exposures, developing cancer prevention frameworks, and tracking long-term clinical survivorship outcomes.
- Immunology, Infection and Cancer: Dissecting tumour-immune interactions, immune evasion mechanisms, pathogen-induced oncogenesis (such as human papillomaviruses and hepatitis viruses), and pioneering novel cancer immunotherapies.
- Imaging, Radiooncology and Oncoengineering: Developing ultra-high-field MRI, novel radiotracers, adaptive radiation oncology methodologies, and bioengineering systems to enhance diagnostic accuracy and therapeutic delivery.
Scientific Core Facilities and Research Infrastructures
To support its internal scientists and external academic partners, DKFZ maintains 21 specialized Scientific Core Facilities. These platforms centralize high-capital instrumentation, standard operating procedures, and dedicated technical expertise:
| Core Facility | Primary Technologies & Platforms | Research Applications |
|---|---|---|
| Next Generation Sequencing (NGS) | High-throughput Illumina sequencers, long-read sequencing, Galaxy bioinformatics workflows | Whole-genome sequencing, RNA-seq, single-cell genomics, and DNA methylation profiling. |
| Light Microscopy Core Facility (LMCF) | Automated slide scanners (e.g., Evident SLIDEVIEW VS200 SILA), confocal, super-resolution microscopy | High-contrast optical sectioning, linear/circular polarization, fluorescence tissue imaging. |
| Flow Cytometry | High-parameter fluorescence sorters, spectral analyzers | Immunophenotyping, rare tumour cell sorting, and immune infiltrate profiling. |
| Proteomics Core Facility | High-resolution mass spectrometers, liquid chromatography systems | Global quantitative proteomics, phosphoproteomics, and biomarker identification. |
| Small Animal Imaging | Pre-clinical micro-CT, micro-PET/SPECT, high-field MRI | In vivo longitudinal tumour tracking and pharmacodynamic biodistribution studies. |
| Data Management & IT Services | Scientific high-performance computing (HPC) clusters, secure biomedical data storage | Pipelined multi-omics data integration, computational biology, and research data management. |
Translational Networks: NCT, DKTK, and KiTZ
DKFZ bridges laboratory discoveries with patient care through dedicated translational oncology networks:
- National Center for Tumor Diseases (NCT): A long-standing comprehensive cancer center alliance between DKFZ, Heidelberg University Hospital, and partner university centers across Germany. NCT unites interdisciplinary clinical oncology teams with laboratory researchers to run early-phase clinical trials following CONSORT flow diagram protocols.
- German Consortium for Translational Cancer Research (DKTK): A national network connecting the central DKFZ hub in Heidelberg with university medical centers at seven partner sites (Berlin, Dresden, Essen/Düsseldorf, Frankfurt/Mainz, Freiburg, Munich, and Tübingen). DKTK standardizes joint clinical trials, shared biobanks, and molecular tumor board workflows across Germany.
- Hopp Children’s Cancer Center Heidelberg (KiTZ): A joint institution dedicated to pediatric oncology, uniting DKFZ, Heidelberg University Hospital, and the Hopp Foundation to develop targeted therapeutics for childhood malignancies.
Understanding these institutional dynamics provides vital context for oncologists and investigators comparing translational structures, such as those detailed in our guide on oncology vs hematology.
Technology Transfer, Innovation, and Industrial Cooperation
DKFZ actively translates biological inventions into clinical products through its Technology Transfer Office. Sourced from official institutional audits, the center’s commercialization footprint encompasses:
- 2,405 Property Rights: Sourced patent filings and granted patents protecting diagnostic targets, imaging reagents, therapeutic antibodies, and pharmacological compounds.
- 275 Active Patent Families: Commercial patent portfolios licensed to biotechnology and pharmaceutical industry partners globally.
- 18 Spin-Off Projects & 22 Corporate Participations: High-growth biotechnology startups founded directly on DKFZ intellectual property to commercialize molecular diagnostics and cancer therapeutics.
Researchers pursuing competitive research support can also consult our comprehensive resources on cancer research funding, federal grant programs like National Cancer Institute (NCI) funding, and major screening initiatives such as the National Lung Screening Trial.
Frequently Asked Questions
What does DKFZ stand for?
DKFZ stands for the Deutsches Krebsforschungszentrum, translated into English as the German Cancer Research Center.
Where is DKFZ located?
The main headquarters and central scientific campus of DKFZ are located in Heidelberg, Germany, within the Neuenheimer Feld biomedical research cluster.
What does DKFZ do?
DKFZ conducts basic, epidemiological, and translational cancer research to elucidate tumor biology, develop innovative cancer prevention strategies, discover novel diagnostic biomarkers, and engineer targeted therapeutic interventions.
How is DKFZ funded?
DKFZ operates with an annual budget of EUR 515 million, funded primarily through basic public grants (90% from the German Federal Ministry of Education and Research and 10% from the State of Baden-Württemberg), alongside competitive project grants and commercial technology transfer licensing.
How do researchers collaborate with DKFZ?
External scientists collaborate with DKFZ through collaborative research agreements, multi-center trials organized by the German Consortium for Translational Cancer Research (DKTK), visiting scientist fellowships, and access to DKFZ’s 21 scientific core facilities.
Sources
- German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). “Facts and Figures.” Official institutional overview, Heidelberg, Germany. URL: https://www.dkfz.de/en/about-us/who-we-are/facts-and-figures (accessed 2026-11-08).
- German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). “Our Research: Programs and Structure.” Official research overview. URL: https://www.dkfz.de/en/forschung/index.html (accessed 2026-11-08).
- German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). “Organization and Management: Management Board.” Leadership profiles. URL: https://www.dkfz.de/en/about-us/organization-and-management/management-board (accessed 2026-11-08).
- German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). “Scientific Core Facilities and Services.” Infrastructure directory and platform descriptions. URL: https://www.dkfz.de/en/forschung/core-facilities (accessed 2026-11-08).
- OpenAlex. “German Cancer Research Center (Institution I130635201).” ROR https://ror.org/04cdgtt98, Heidelberg, Germany. URL: https://api.openalex.org/institutions?search=Deutsches%20Krebsforschungszentrum (accessed 2026-11-08).
